Skip to main content
SpringerLink
Log in

PROSTATE CANCER

Promising long-term results with proton therapy for localized prostate cancer

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

The value of proton therapy in managing prostate cancer is not yet defined. A recent study has reported promising long-term results for patients with localized prostate cancer who received proton therapy. However, results from ongoing clinical trials are required before determining the role of proton therapy for this indication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Trofimov, A. et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int. J. Radiat. Oncol. Biol. Phys. 69, 444–453 (2007).

    Article  Google Scholar 

  2. Vargas, C. et al. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 70, 744–751 (2008).

    Article  Google Scholar 

  3. Pan, H. Y. et al. Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer. J. Clin. Oncol. 36, 1823–1830 (2018).

    Article  CAS  Google Scholar 

  4. Xiang, M., Chang, D. T. & Pollom, E. L. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 126, 3560–3568 (2020).

    Article  Google Scholar 

  5. Suit, H. et al. Proton beams to replace photon beams in radical dose treatments. Acta. Oncol. 42, 800–808 (2003).

    Article  Google Scholar 

  6. Takagi, M. et al. Proton therapy for localized prostate cancer: long-term results from a single-center experience. Int. J. Radiat. Oncol. Biol. Phys. https://doi.org/10.1016/j.ijrobp.2020.11.007 (2020).

    Article  PubMed  Google Scholar 

  7. Roach, M. 3rd et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 65, 965–974 (2006).

    Article  Google Scholar 

  8. Hoppe, B. S. et al. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer 120, 1076–1082 (2014).

    Article  Google Scholar 

  9. Morris, W. J. et al. Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 98, 275–285 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA

    Curtis M. Bryant

  2. Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA

    Bradford S. Hoppe

Authors
  1. Curtis M. Bryant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradford S. Hoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Curtis M. Bryant.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links

COMPPARE trial: https://clinicaltrials.gov/ct2/show/NCT03561220

PARTIQoL trial: https://clinicaltrials.gov/ct2/show/NCT01617161

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bryant, C.M., Hoppe, B.S. Promising long-term results with proton therapy for localized prostate cancer. Nat Rev Urol 18, 137–138 (2021). https://doi.org/10.1038/s41585-021-00429-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-021-00429-5

  • Springer Nature Limited

Search

Navigation